Subscribe to RSS
DOI: 10.1055/a-2030-7826
Organophotoredox-Catalyzed Oxidative C(sp2)–H Alkylation of N-Heteroarenes with Dihydroquinazolinones by C–C Cleavage
This work was supported by SERB, India (File: SRG/2021/000572). P.P.M. and A.P. thank the Ministry of Education, India for their Prime Minister’s Research Fellowship. S.D. thanks UGC, India for research fellowship.
Dedicated to Professor Matthias Beller on his 60th birthday
Abstract
We report a visible-light-mediated, organophotoredox-catalyzed, C(sp2)–H alkylation of N-heteroarenes with dihydroquinazolines, prepared from aliphatic ketones, under oxidative conditions. This protocol represents a metal-free approach to the effective construction of C–C bonds through a Minisci-type reaction, formally activating the native C–H bond of the N-heteroarene and an α-C–C bond of a readily available ketone. The mild nature of this method accommodates a wide variety of N-heteroarenes and ketones, tolerating a wide range of functional groups.
#
N-Heteroarenes form the privileged core structures of many naturally occurring alkaloids,[1] pharmaceutical drugs,[2] agrochemicals,[3] and functional materials.[4] Encouraged by the beneficial effects of an enhanced C(sp3) fraction in prodrugs or lead structures for drug discovery,[5] the selective alkylation of N-heteroarenes has recently gained prominence as a method for building up structural complexity in molecular skeletons.[6] In this regard, the catalytic C–H alkylation of electron-deficient N-heteroarenes (the Minisci-type reaction) is typically used for the direct installation of a C(sp3) fragment onto an N-heteroaryl core.[6] Whereas the classic Minisci reaction of N-heteroarenes with aliphatic carboxylic acids has limitations under relatively harsh conditions,[7] the monumental development of visible-light photocatalysis[8] has enabled a broadening of the range of alkyl-radical precursors to include alkyl halides,[9`] [b] [c] alkylborates[9d,e] or alkylsilicates,[9f] alcohols,[9`] [h] [i] aldehydes[9j] [k] aldehyde-derived dihydropyridines,[9l] carboxylic acids[9`] [n] [o] or their redox-active esters,[9`] [q] [r] amine-derived pyridinium salts,[9s] or even native C–H bonds,[9`] [u] [v] [w] [x] [y] among others[9z] for the alkylation of heteroarenes (Scheme [1]).[9]


The ketone group is recognized as a versatile functionality and an integral part of various commodity chemicals, natural products, and pharmaceuticals.[10] However, due to the lack of an effective orbital interaction, α-C–C bond functionalization of aliphatic ketones has remained a thought-provoking task[11] compared with conventional nucleophilic additions or α-C–H functionalizations. Recently, the tactic of converting ketones into proaromatic dihydroquinazolinones and their subsequent aromatization-driven C–C bond cleavage has emerged as a promising technique for the functionalization of ketone C–C bonds.[12] In this context, the Zhu group disclosed a photocatalytic activation of ketone-derived dihydroquinazolinones toward a Giese reaction with activated alkenes.[12a] Furthermore, the groups of Martin and Liao have evaluated such dihydroquinazolinones as efficient alkyl-radical precursors in metallaphotoredox-catalyzed C–C cross-couplings with aryl or alkyl bromides[12b] [c] or electrophilic Togni’s reagent.[12d] We recently reported a thermal activation of dihydroquinazolinones towards catalytic alkylation of native C–H bonds of N-heteroarenes under oxidative metal catalysis.[12e] Here, we report an alternative approach to the oxidative C(sp2)–H alkylation of various N-heteroarenes by using dihydroquinazolinones under visible-light photoredox catalysis. In this protocol, the reaction is performed without any metal catalyst by using an organic dye as a photosensitizer and visible light as a renewable energy source.
As dictated by our previous studies,[12e] at the outset of this investigation we optimized the reaction by treating lepidine (1a) with the cyclohexyl methyl ketone-derived dihydroquinazolinone 2a (2.5 equiv) in the presence of 2,4,5,6-tetrakis(9H-carbazol-9-yl)isophthalonitrile (4CzIPN; 2 mol%) and K2S2O8 (2.0 equiv) in DMF (0.2 M) under visible-light irradiation from blue LEDs (λmax = 456 nm) for 18 hours, affording the alkylated product 3aa in 76% isolated yield (Table [1], entry 1). Surprisingly, the use of rose bengal or eosin Y as an organic dye instead of 4CzIPN gave 3aa in reduced yields (entries 2 and 3). A survey of the sacrificial oxidant showed that (NH4)2S2O8 or N-fluorobenzenesulfonimide (NFSI) gave 3aa in slightly reduced yields, whereas di-tert-butyl peroxide (DTBP) was completely ineffective (entries 4–6). Altering the solvent from DMF to N-methyl-2-pyrrolidone (NMP) or 1,2-dichloroethane (DCE) led to a marked reduction in the yield of 3aa (entries 7 and 8). Furthermore, a 23 W compact fluorescent lamp (CFL) was found to be ineffective in this transformation (entry 9). Moreover, the reduction of the amount of 2a or the 4CzIPN reduced the efficiency of this transformation (entries 10 and 11). Control experiments confirmed the critical roles of 4CzIPN, K2S2O8, and light in achieving the desired reactivity (entries 12–14).
a Standard conditions: 1a (0.10 mmol), 2a (0.25 mmol), 4CzIPN (2 mol%), K2S2O8 (0.20 mmol), DMF (0.5 mL), rt, 18 h, blue LEDs.
b Isolated yield.
Having identified the optimal conditions, we set out to evaluate the scope of the dihydroquinazolinone in reactions with lepidine (1a; Scheme [2]). Preferential cleavage of the C–C bond of the dihydroquinazolinone is dictated by the bond strength and stability of the incipient radical.[12f] Initially, an acyclic isopropyl methyl ketone-derived dihydroquinazolinone 2b was found to be a competent partner, delivering the alkylated product 3ab in 64% yield. Furthermore, the dihydroquinazolinone 2c, featuring a heterocyclic tetrahydropyran moiety, exhibited the desired reactivity, furnishing the product 3ac in 55% yield. Likewise, the dihydroquinazolinone 2d furnished the expected product 3ad in 47% yield. Pleasingly, the dihydroquinazolinone 2e, prepared from benzyl phenyl ketone, served as a viable substrate in this transformation, providing the product 3ae in 41% yield through preferential cleavage of the C(sp3)–C(sp3) bond over the C(sp3)–C(sp2) bond. Gratifyingly, the dihydroquinazolinones 2f and 2g, synthesized from 1-(1-arylcycloalkyl)ethan-1-ones, were effective substrates under the optimal conditions, affording the products 3af and 3ag in yields of 77 and 82%, respectively; these products resemble the lead structures of a selectin inhibitor.[13]. Notably, the pivalaldehyde-derived dihydroquinazolinone 2h exhibited competency in this transformation, delivering the desired product 3ah in 68% yield, indicating a proclivity for the cleavage of the C–C bond in preference to the C–H bond. In view of the scalability and practicability of this protocol, the dihydroquinazolinone 2b was synthesized in situ from cyclohexyl methyl ketone and anthranilamide and used directly, without purification, in a C–H alkylation of lepidine (1.0 mmol scale) under the standard conditions, giving product 3aa in 65% yield (Scheme [2]).


Next, we turned our attention to a study of the scope of the N-heteroarene in reactions with the dihydroquinazoline 2a (Scheme [3]). As predicted from their Fukui indices, several N-heteroarenes, including pyridine and quinoline, underwent C–H alkylations at a C-2 or C-4 site.[] Quinoline 1b, containing a p-(trifluoromethyl)phenyl group at the C-4 position, was effectively alkylated at the C-2 site to give product 3ba in 64% yield. Interestingly, the ester (1c) and amide (1d) derivatives of the quinoline-2-carboxylic acid obtained from l-menthol and piperidine, were also viable substrates, affording the products 3ca and 3da in yields of 52 and 51%, respectively, upon C–H alkylation at the C-4 site. Gratifyingly, the benzoxazole 1e and the N-benzyl-protected benzimidazole 1f exhibited the desired reactivity, delivering products 3ea and 3fa in yields of 59 and 41%, respectively. As expected, the isoquinolines 1g and 1h with phenyl and p-anisidinyl substituents, respectively, at the C-6 position participated successfully in this transformation, affording the corresponding products 3ga and 3ha, in yields of 75% and 76% respectively. Notably, 1-methylquinolin-2(1H)-one (1i) was found to be an effective substrate under the optimal conditions, providing product 3ia in 39% yield. To our delight, 4-(trifluoromethyl)pyridine (1j) was also a successful substrate under this optimized protocol for C–H alkylation, delivering the dialkylated product 3ja in 40% yield. Encouraged by the critical role of N-donor ligands (e.g., bipyridines) in transition-metal catalysis, we applied the current protocol to the bipyridines 1k and 1l, featuring an electron-rich tert-butyl and an electron-withdrawing ester functionality, respectively, and we obtained the corresponding structurally modulated bipyridines as separable monoalkylated [3ka (51%) and 3la (27%)] and dialkylated products [3ka′ (9%) + 3la′ (7%)].


To elucidate the mechanistic intricacies of this photochemical transformation, we conducted some preliminary mechanistic experiments and spectroscopic studies. Our initial control experiments indicated the critical roles of the 4CzIPN photocatalyst, light, and the K2S2O8 oxidant in this transformation (Table [1], entries 11–13). In a radical-inhibition experiment, when the standard reaction was executed in the presence of TEMPO as a radical scavenger, the formation of product 3aa was significantly suppressed, and an adduct between the cyclohexyl radical and the TEMPO radical was detected by HRMS analysis, suggesting the involvement of a radical intermediate (Scheme [4a]). Furthermore, the reaction was also inhibited when it was carried out in the presence of 1,1-diphenylethene (DPE) as a radical-trapping agent (Scheme [4b]). Luminescence-quenching plots and a Stern–Volmer plot suggested that the 4CzIPN excited state is quenched by the dihydroquinazoline 2a,[12b] rather than by lepidine (1a) or K2S2O8 (Scheme [4c]).


On the basis of the preliminary mechanistic studies and previous reports,[9] we suggest the tentative mechanism shown in Scheme [5]. Initially, photoexcited 4CzIPN* is generated from ground-state 4CzIPN by visible-light irradiation. Quenching of 4CzIPN* (E red = +1.35 V vs SCE)[14] with 2a (E ox = +0.98 V vs SCE)[15] gives the reduced photocatalyst 4CzIPN∙– and the intermediate Int-I, which rapidly undergoes C–C bond cleavage, driven by aromatization, to liberate a nascent cyclohexyl radical and the quinazolinone 6 as a byproduct.[9] Subsequently, the addition of the cyclohexyl radical to the activated lepidine generates intermediate Int-II. Concurrently, the single-electron reduction of S2O8 2– by 4CzIPN∙– regenerates 4CzIPN in the ground state and SO4 2– along with an SO4 ∙– radical anion that engages in hydrogen atom transfer (HAT) with Int-II,[9w] [12e] furnishing the final product 3aa.


In summary, we have developed a mild protocol for C(sp2)–H alkylation of a variety of N-heteroaromatic compounds with ketone-derived dihydroquinazolinones under a visible-light organophotoredox catalytic regime.[16] Activation of the N-heteroarene C–H bond and the ketone C–C bond was amalgamated under net oxidative conditions to accomplish the targeted C–C bond formation through a Minisci reaction. Due to mild nature, this methodology is applicable to a broad range of N-heteroarenes and ketones, as well as tolerating distinct functionalities and demonstrating scalability and practicability.
#
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgment
Infrastructural support from IISER Thiruvananthapuram is gratefully acknowledged.
Supporting Information
- Supporting information for this article is available online at https://doi-org.accesdistant.sorbonne-universite.fr/10.1055/a-2030-7826.
- Supporting Information
-
References and Notes
- 1a Newman DJ, Cragg GM. J. Nat. Prod. 2020; 83: 770
- 1b Michael JP. Nat. Prod. Rep. 2005; 22: 627
- 1c O’Hagan D. Nat. Prod. Rep. 2000; 17: 435
- 2a Heravi MM, Zadsirijan V. RSC Adv. 2020; 10: 44247
- 2b Vitaku ED, Smith T, Njardarson JT. J. Med. Chem. 2014; 57: 10257
- 2c Venditto VJ, Simanek EE. Mol. Pharmaceutics 2010; 7: 307
- 3 Guan A.-Y, Liu C.-L, Sun X.-F, Xie Y, Wang M.-A. Bioorg. Med. Chem. 2016; 24: 342
- 4 Leclerc N, Sanaur S, Galmiche L, Mathevet F, Attias A.-J, Fave J.-L, Roussel J, Hapiot P, Lemaître N, Geffroy B. Chem. Mater. 2005; 17: 502
- 5a Lovering F, Bikker J, Humblet C. J. Med. Chem. 2009; 52: 6752
- 5b Talele TT. J. Med. Chem. 2020; 63: 13291
- 6a Duncton MA. J. Med. Chem. Commun. 2011; 2: 1135
- 6b Procter RS. J, Phipps RJ. Angew. Chem. Int. Ed. 2019; 58: 13666
- 6c Parida SK, Hota SK, Kumar R, Murarka S. Chem. Asian J. 2021; 16: 879
- 6d Ghosh A, Pyne P, Ghosh S, Ghosh D, Majumder S, Hajra A. Green Chem. 2022; 24: 3056
- 7a Minisci F, Bernardi R, Bertini F, Galli R. Tetrahedron 1971; 27: 3575
- 7b Minisci F, Vismara E, Fontana F. Heterocycles 1989; 28: 489
- 8a Juliá F, Constantin T, Leonori D. Chem. Rev. 2022; 122: 2292
- 8b Huang C.-Y, Li J, Li C.-J. Chem. Sci. 2022; 13: 5465
- 8c Liu Q, Huo C, Fu Y, Du Z. Org. Biomol. Chem. 2022; 20: 6721
- 8d Bortolato T, Cuadros S, Simionato G, Dell’Amico L. Chem. Commun. 2022; 58: 1263
- 8e Hota SK, Jinan D, Panda SP, Pan R, Sahoo B. Asian J. Org. Chem. 2021; 10: 1848
- 8f Crespi S, Fagnoni M. Chem. Rev. 2020; 120: 9790
- 9a Santos MS, Cybularczyk-Cecotka M, König B, Giedyk M. Chem. Eur. J. 2020; 26: 15323
- 9b Dong J, Lyu X, Wang Z, Wang X, Song H, Liu Y, Wang Q. Chem. Sci. 2019; 10: 976
- 9c Wang Z, Dong J, Hao Y, Li Y, Liu Y, Song H, Wang Q. J. Org. Chem. 2019; 84: 16245
- 9d Li J, Huang C.-Y, Han J.-T, Li C.-J. ACS Catal. 2021; 11: 14148
- 9e Yan H, Hou Z.-W, Xu H.-C. Angew. Chem. Int. Ed. 2019; 58: 4592
- 9f Ikarashi G, Morofuji T, Kano N. Chem. Commun. 2020; 56: 10006
- 9g Xu F, Lai X.-L, Xu H.-C. Synlett 2021; 32: 369
- 9h Pitre SP, Muuronen M, Fishman DA, Overman LE. ACS Catal. 2019; 9: 3413
- 9i Jin J, MacMillan DW. C. Nature 2015; 525: 87
- 9j Wang X, Shao X, Cao Z, Wu X, Zhu C. Adv. Synth. Catal. 2022; 364: 1200
- 9k Wang Z, Ji X, Zhao J, Huang H. Green Chem. 2019; 21: 5512
- 9l Chen X, Luo X, Wang K, Liang F, Wang P. Synlett 2021; 32: 733
- 9m Lai X, Shu X, Song J, Xu H.-C. Angew. Chem. Int. Ed. 2020; 59: 10626
- 9n Zhang X.-Y, Weng W.-Z, Liang H, Yang H, Zhang B. Org. Lett. 2018; 20: 4686
- 9o Garza-Sanchez RA, Tlahuext-Aca A, Tavakoli G, Glorius F. ACS Catal. 2017; 7: 4057 ; corrigendum: ACS Catal. 2022, 12, 6640
- 9p Li J, Tan SS, Kyne SH, Chan PW. H. Adv. Synth. Catal. 2022; 364: 802
- 9q Procter RS. J, Davis HJ, Phipps RJ. Science 2018; 360: 419
- 9r Chen W.-M, Shang R, Fu M.-C, Fu Y. Chem. Eur. J. 2017; 23: 2537
- 9s Wang K, Liu X, Yang S, Tian Y, Zhou M, Zhou J, Jia X, Li B, Liu S, Chen J. Org. Lett. 2022; 24: 3471
- 9t Li D.-S, Liu T, Hong Y, Cao C.-L, Wu J, Deng H.-P. ACS Catal. 2022; 12: 4473
- 9u Bhakat M, Khatua B, Guin J. Org. Lett. 2022; 24: 5276
- 9v Zhang L, Pfund B, Wenger OS, Hu X. Angew. Chem. Int. Ed. 2022; 61: e202202649
- 9w Tian H, Yang H, Tian C, An G, Li G. Org. Lett. 2020; 22: 7709
- 9x Rammal F, Gao D, Boujnah S, Gaumont AC, Hussein AA, Lakhdar S. Org. Lett. 2020; 22: 7671
- 9y Zhao H, Jin J. Org. Lett. 2019; 21: 6179
- 9z Dong J, Yue F, Song H, Liu Y, Wang Q. Chem. Commun. 2020; 56: 12652
- 10a Kim Y.-S, Shin D.-H. J. Agric. Food Chem. 2004; 52: 781
- 10b Baser KH. C, Özek T, Akgül A, Tümen G. J. Essent. Oil Res. 1993; 5: 215
- 10c Ertl P, Schuhmann T. J. Nat. Prod. 2019; 82: 1258
- 10d Cao S, Foster C, Lazo JS, Kingston DG. I. Bioorg. Med. Chem. 2005; 13: 5830
- 11a Xia Y, Dong G. Nat. Rev. Chem. 2020; 4: 600
- 11b Deng L, Dong G. Trends Chem. 2020; 2: 183
- 11c Fumagalli G, Stanton S, Bower JF. Chem. Rev. 2017; 117: 9404
- 12a Li L, Fang L, Wu W, Zhu J. Org. Lett. 2020; 22: 5401
- 12b Lv X.-Y, Abrams R, Martin R. Nat. Commun. 2022; 13: 2394
- 12c Lee S.-C, Li L.-Y, Tsai Z.-N, Lee Y.-H, Tsao Y.-T, Huang P.-G, Cheng C.-K, Lin H.-B, Chen T.-W, Yang C.-H, Chiu C.-C, Liao H.-H. Org. Lett. 2022; 24: 85
- 12d Cong F, Mega RS, Chen J, Day CS, Martin R. Angew. Chem. Int. Ed. 2022; in press; DOI
- 12e Mondal PP, Pal A, Prakash AK, Sahoo B. Chem. Commun. 2022; 58: 13202
- 12f Lv X.-Y, Abrams R, Martin R. Angew. Chem. Int. Ed. 2022; 62: e202217386
- 13 Kaila N, Janz KM, Huang A, Moretto AF, Bedard PW. ; WO 2008121817, 2008
- 14 Shang T.-Y, Lu L.-H, Cao Z, Liu Y, He W.-M, Yu B. Chem. Commun. 2019; 55: 5408
- 15 See the Supporting Information.
- 16 Compounds 3; General Procedure In a heat-gun-dried Schlenk tube equipped with a Teflon-coated stirrer bar, the appropriate N-heteroarene 1 (0.2 mmol, 1.0 equiv), dihydroquinazolinone substrate 2 (0.5 mmol, 2.5 equiv), 4CzIPN (0.004 mmol, 2 mol%), and K2S2O8 (0.4 mmol, 2.0 equiv) were dissolved in anhyd DMF (1 mL) under an inert atmosphere. The mixture was stirred at rt for 18 h in the presence of light from blue LEDs. The reaction was then quenched by the addition of aq Na2CO3 (2 mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with H2O (5 mL) and brine (5 mL), and the solvents were removed under reduced pressure. The crude residue was purified by flash column chromatography (silica gel, PE–EtOAc).2-Cyclohexyl-4-methylquinoline (3aa)Colorless liquid; yield: 73%. 1H NMR (500 MHz, CDCl3): δ = 8.15 (d, J = 8.4 Hz, 1 H), 8.03 (d, J = 8.3 Hz, 1 H), 7.75 (ddd, J = 8.3, 6.9, 1.4 Hz, 1 H), 7.60 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H), 7.26 (s, 1 H), 2.98 (tt, J = 12.1, 3.4 Hz, 1 H), 2.75 (s, 3 H), 2.10–2.12 (m, 2 H), 1.98 (dt, J = 12.8, 3.0 Hz, 2 H), 1.77–1.81 (m, 1 H), 1.62 (qd, J = 12.6, 3.1 Hz, 2 H), 1.62 (qt, J = 12.8, 3.3 Hz, 2 H), 1.44 (tt, J = 12.8, 3.6 Hz, 1 H). 13C NMR (126 MHz, CDCl3): δ = 166.7, 147.8, 144.4, 129.7, 129.1, 127.2, 125.5, 123.7, 120.4, 47.8, 33.0, 26.7, 26.3, 19.0.4-Methyl-2-(1-phenylcyclopropyl)quinoline (3af)Colorless liquid; yield: 77%. 1H NMR (500 MHz, CDCl3): δ = 8.03 (d, J = 8.5 Hz, 1 H), 7.90 (d, J = 8.3 Hz, 1 H), 7.67 (ddd, J = 8.4, 6.9, 1.3 Hz, 1 H), 7.48 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H), 7.43–7.45 (m, 2 H), 7.36–7.39 (m, 2 H), 7.28–7.30 (m, 1 H), 6.95 (s, 1 H), 2.55 (s, 3 H), 1.81 (dd, J = 6.2, 3.5 Hz, 2 H), 1.36 (dd, J = 6.5, 3.8 Hz, 2 H). 13C NMR (126 MHz, CDCl3): δ = 163.9, 147.8, 144.0, 143.6, 130.3, 129.8, 129.1, 128.7, 126.8, 126.7, 125.5, 123.7, 122.1, 32.3, 18.8, 17.3.(4-Cyclohexylquinolin-2-yl)(piperidin-1-yl)methanon (3da)Colorless liquid; yield: 51%. 1H NMR (500 MHz, CDCl3): δ = 8.01–8.31 (m, 2 H), 7.70 (t, J = 7.6 Hz, 1 H), 7.58 (t, J = 7.7 Hz, 1 H), 7.51 (s, 1 H), 3.78–3.80 (m, 2 H), 3.47–3.49 (m, 2 H), 3.30–3.36 (m, 1 H), 2.00–2.02 (m, 2 H), 1.91–1.94 (m, 2 H), 1.82–1.85 (m, 1 H), 1.67–1.74 (m, 4 H), 1.49–1.61 (m, 6 H), 1.29–1.37 (m, 1 H). 13C NMR (126 MHz, CDCl3): δ = 168.3, 154.8, 154.6, 147.2, 130.9, 129.4, 127.0, 126.8, 123.1, 116.8, 48.5, 43.4, 39.3, 33.6, 27.0, 26.7, 26.4, 25.7, 24.8.1-Cyclohexyl-6-(4-methoxyphenyl)isoquinoline (3ha)White solid; yield: 76%; mp 118 °C. 1H NMR (500 MHz, CDCl3): δ = 8.48 (d, J = 5.7 Hz, 1 H), 8.26 (d, J = 8.9 Hz, 1 H), 7.93 (d, J = 1.6 Hz, 1 H), 7.80 (dd, J = 8.8, 1.8 Hz, 1 H), 7.66–7.68 (m, 2 H), 7.50 (d, J = 5.7 Hz, 1 H), 7.03–7.05 (m, 2 H), 3.88 (s, 3 H), 3.57 (tt, J = 11.7, 3.2 Hz, 1 H), 1.93–2.01 (m, 4 H), 1.80–1.88 (m, 3 H), 1.50–1.57 (m, 2 H), 1.38–1.44 (m, 1 H). 13C NMR (126 MHz, CDCl3): δ = 165.7, 160.0, 142.5, 141.9, 137.0, 132.8, 128.7, 126.4, 125.5, 125.2, 124.5, 119.2, 114.6, 55.6, 41.8, 32.8, 27.1, 26.4.
Corresponding Author
Publication History
Received: 24 December 2022
Accepted after revision: 08 February 2023
Accepted Manuscript online:
08 February 2023
Article published online:
09 March 2023
© 2023. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References and Notes
- 1a Newman DJ, Cragg GM. J. Nat. Prod. 2020; 83: 770
- 1b Michael JP. Nat. Prod. Rep. 2005; 22: 627
- 1c O’Hagan D. Nat. Prod. Rep. 2000; 17: 435
- 2a Heravi MM, Zadsirijan V. RSC Adv. 2020; 10: 44247
- 2b Vitaku ED, Smith T, Njardarson JT. J. Med. Chem. 2014; 57: 10257
- 2c Venditto VJ, Simanek EE. Mol. Pharmaceutics 2010; 7: 307
- 3 Guan A.-Y, Liu C.-L, Sun X.-F, Xie Y, Wang M.-A. Bioorg. Med. Chem. 2016; 24: 342
- 4 Leclerc N, Sanaur S, Galmiche L, Mathevet F, Attias A.-J, Fave J.-L, Roussel J, Hapiot P, Lemaître N, Geffroy B. Chem. Mater. 2005; 17: 502
- 5a Lovering F, Bikker J, Humblet C. J. Med. Chem. 2009; 52: 6752
- 5b Talele TT. J. Med. Chem. 2020; 63: 13291
- 6a Duncton MA. J. Med. Chem. Commun. 2011; 2: 1135
- 6b Procter RS. J, Phipps RJ. Angew. Chem. Int. Ed. 2019; 58: 13666
- 6c Parida SK, Hota SK, Kumar R, Murarka S. Chem. Asian J. 2021; 16: 879
- 6d Ghosh A, Pyne P, Ghosh S, Ghosh D, Majumder S, Hajra A. Green Chem. 2022; 24: 3056
- 7a Minisci F, Bernardi R, Bertini F, Galli R. Tetrahedron 1971; 27: 3575
- 7b Minisci F, Vismara E, Fontana F. Heterocycles 1989; 28: 489
- 8a Juliá F, Constantin T, Leonori D. Chem. Rev. 2022; 122: 2292
- 8b Huang C.-Y, Li J, Li C.-J. Chem. Sci. 2022; 13: 5465
- 8c Liu Q, Huo C, Fu Y, Du Z. Org. Biomol. Chem. 2022; 20: 6721
- 8d Bortolato T, Cuadros S, Simionato G, Dell’Amico L. Chem. Commun. 2022; 58: 1263
- 8e Hota SK, Jinan D, Panda SP, Pan R, Sahoo B. Asian J. Org. Chem. 2021; 10: 1848
- 8f Crespi S, Fagnoni M. Chem. Rev. 2020; 120: 9790
- 9a Santos MS, Cybularczyk-Cecotka M, König B, Giedyk M. Chem. Eur. J. 2020; 26: 15323
- 9b Dong J, Lyu X, Wang Z, Wang X, Song H, Liu Y, Wang Q. Chem. Sci. 2019; 10: 976
- 9c Wang Z, Dong J, Hao Y, Li Y, Liu Y, Song H, Wang Q. J. Org. Chem. 2019; 84: 16245
- 9d Li J, Huang C.-Y, Han J.-T, Li C.-J. ACS Catal. 2021; 11: 14148
- 9e Yan H, Hou Z.-W, Xu H.-C. Angew. Chem. Int. Ed. 2019; 58: 4592
- 9f Ikarashi G, Morofuji T, Kano N. Chem. Commun. 2020; 56: 10006
- 9g Xu F, Lai X.-L, Xu H.-C. Synlett 2021; 32: 369
- 9h Pitre SP, Muuronen M, Fishman DA, Overman LE. ACS Catal. 2019; 9: 3413
- 9i Jin J, MacMillan DW. C. Nature 2015; 525: 87
- 9j Wang X, Shao X, Cao Z, Wu X, Zhu C. Adv. Synth. Catal. 2022; 364: 1200
- 9k Wang Z, Ji X, Zhao J, Huang H. Green Chem. 2019; 21: 5512
- 9l Chen X, Luo X, Wang K, Liang F, Wang P. Synlett 2021; 32: 733
- 9m Lai X, Shu X, Song J, Xu H.-C. Angew. Chem. Int. Ed. 2020; 59: 10626
- 9n Zhang X.-Y, Weng W.-Z, Liang H, Yang H, Zhang B. Org. Lett. 2018; 20: 4686
- 9o Garza-Sanchez RA, Tlahuext-Aca A, Tavakoli G, Glorius F. ACS Catal. 2017; 7: 4057 ; corrigendum: ACS Catal. 2022, 12, 6640
- 9p Li J, Tan SS, Kyne SH, Chan PW. H. Adv. Synth. Catal. 2022; 364: 802
- 9q Procter RS. J, Davis HJ, Phipps RJ. Science 2018; 360: 419
- 9r Chen W.-M, Shang R, Fu M.-C, Fu Y. Chem. Eur. J. 2017; 23: 2537
- 9s Wang K, Liu X, Yang S, Tian Y, Zhou M, Zhou J, Jia X, Li B, Liu S, Chen J. Org. Lett. 2022; 24: 3471
- 9t Li D.-S, Liu T, Hong Y, Cao C.-L, Wu J, Deng H.-P. ACS Catal. 2022; 12: 4473
- 9u Bhakat M, Khatua B, Guin J. Org. Lett. 2022; 24: 5276
- 9v Zhang L, Pfund B, Wenger OS, Hu X. Angew. Chem. Int. Ed. 2022; 61: e202202649
- 9w Tian H, Yang H, Tian C, An G, Li G. Org. Lett. 2020; 22: 7709
- 9x Rammal F, Gao D, Boujnah S, Gaumont AC, Hussein AA, Lakhdar S. Org. Lett. 2020; 22: 7671
- 9y Zhao H, Jin J. Org. Lett. 2019; 21: 6179
- 9z Dong J, Yue F, Song H, Liu Y, Wang Q. Chem. Commun. 2020; 56: 12652
- 10a Kim Y.-S, Shin D.-H. J. Agric. Food Chem. 2004; 52: 781
- 10b Baser KH. C, Özek T, Akgül A, Tümen G. J. Essent. Oil Res. 1993; 5: 215
- 10c Ertl P, Schuhmann T. J. Nat. Prod. 2019; 82: 1258
- 10d Cao S, Foster C, Lazo JS, Kingston DG. I. Bioorg. Med. Chem. 2005; 13: 5830
- 11a Xia Y, Dong G. Nat. Rev. Chem. 2020; 4: 600
- 11b Deng L, Dong G. Trends Chem. 2020; 2: 183
- 11c Fumagalli G, Stanton S, Bower JF. Chem. Rev. 2017; 117: 9404
- 12a Li L, Fang L, Wu W, Zhu J. Org. Lett. 2020; 22: 5401
- 12b Lv X.-Y, Abrams R, Martin R. Nat. Commun. 2022; 13: 2394
- 12c Lee S.-C, Li L.-Y, Tsai Z.-N, Lee Y.-H, Tsao Y.-T, Huang P.-G, Cheng C.-K, Lin H.-B, Chen T.-W, Yang C.-H, Chiu C.-C, Liao H.-H. Org. Lett. 2022; 24: 85
- 12d Cong F, Mega RS, Chen J, Day CS, Martin R. Angew. Chem. Int. Ed. 2022; in press; DOI
- 12e Mondal PP, Pal A, Prakash AK, Sahoo B. Chem. Commun. 2022; 58: 13202
- 12f Lv X.-Y, Abrams R, Martin R. Angew. Chem. Int. Ed. 2022; 62: e202217386
- 13 Kaila N, Janz KM, Huang A, Moretto AF, Bedard PW. ; WO 2008121817, 2008
- 14 Shang T.-Y, Lu L.-H, Cao Z, Liu Y, He W.-M, Yu B. Chem. Commun. 2019; 55: 5408
- 15 See the Supporting Information.
- 16 Compounds 3; General Procedure In a heat-gun-dried Schlenk tube equipped with a Teflon-coated stirrer bar, the appropriate N-heteroarene 1 (0.2 mmol, 1.0 equiv), dihydroquinazolinone substrate 2 (0.5 mmol, 2.5 equiv), 4CzIPN (0.004 mmol, 2 mol%), and K2S2O8 (0.4 mmol, 2.0 equiv) were dissolved in anhyd DMF (1 mL) under an inert atmosphere. The mixture was stirred at rt for 18 h in the presence of light from blue LEDs. The reaction was then quenched by the addition of aq Na2CO3 (2 mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with H2O (5 mL) and brine (5 mL), and the solvents were removed under reduced pressure. The crude residue was purified by flash column chromatography (silica gel, PE–EtOAc).2-Cyclohexyl-4-methylquinoline (3aa)Colorless liquid; yield: 73%. 1H NMR (500 MHz, CDCl3): δ = 8.15 (d, J = 8.4 Hz, 1 H), 8.03 (d, J = 8.3 Hz, 1 H), 7.75 (ddd, J = 8.3, 6.9, 1.4 Hz, 1 H), 7.60 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H), 7.26 (s, 1 H), 2.98 (tt, J = 12.1, 3.4 Hz, 1 H), 2.75 (s, 3 H), 2.10–2.12 (m, 2 H), 1.98 (dt, J = 12.8, 3.0 Hz, 2 H), 1.77–1.81 (m, 1 H), 1.62 (qd, J = 12.6, 3.1 Hz, 2 H), 1.62 (qt, J = 12.8, 3.3 Hz, 2 H), 1.44 (tt, J = 12.8, 3.6 Hz, 1 H). 13C NMR (126 MHz, CDCl3): δ = 166.7, 147.8, 144.4, 129.7, 129.1, 127.2, 125.5, 123.7, 120.4, 47.8, 33.0, 26.7, 26.3, 19.0.4-Methyl-2-(1-phenylcyclopropyl)quinoline (3af)Colorless liquid; yield: 77%. 1H NMR (500 MHz, CDCl3): δ = 8.03 (d, J = 8.5 Hz, 1 H), 7.90 (d, J = 8.3 Hz, 1 H), 7.67 (ddd, J = 8.4, 6.9, 1.3 Hz, 1 H), 7.48 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H), 7.43–7.45 (m, 2 H), 7.36–7.39 (m, 2 H), 7.28–7.30 (m, 1 H), 6.95 (s, 1 H), 2.55 (s, 3 H), 1.81 (dd, J = 6.2, 3.5 Hz, 2 H), 1.36 (dd, J = 6.5, 3.8 Hz, 2 H). 13C NMR (126 MHz, CDCl3): δ = 163.9, 147.8, 144.0, 143.6, 130.3, 129.8, 129.1, 128.7, 126.8, 126.7, 125.5, 123.7, 122.1, 32.3, 18.8, 17.3.(4-Cyclohexylquinolin-2-yl)(piperidin-1-yl)methanon (3da)Colorless liquid; yield: 51%. 1H NMR (500 MHz, CDCl3): δ = 8.01–8.31 (m, 2 H), 7.70 (t, J = 7.6 Hz, 1 H), 7.58 (t, J = 7.7 Hz, 1 H), 7.51 (s, 1 H), 3.78–3.80 (m, 2 H), 3.47–3.49 (m, 2 H), 3.30–3.36 (m, 1 H), 2.00–2.02 (m, 2 H), 1.91–1.94 (m, 2 H), 1.82–1.85 (m, 1 H), 1.67–1.74 (m, 4 H), 1.49–1.61 (m, 6 H), 1.29–1.37 (m, 1 H). 13C NMR (126 MHz, CDCl3): δ = 168.3, 154.8, 154.6, 147.2, 130.9, 129.4, 127.0, 126.8, 123.1, 116.8, 48.5, 43.4, 39.3, 33.6, 27.0, 26.7, 26.4, 25.7, 24.8.1-Cyclohexyl-6-(4-methoxyphenyl)isoquinoline (3ha)White solid; yield: 76%; mp 118 °C. 1H NMR (500 MHz, CDCl3): δ = 8.48 (d, J = 5.7 Hz, 1 H), 8.26 (d, J = 8.9 Hz, 1 H), 7.93 (d, J = 1.6 Hz, 1 H), 7.80 (dd, J = 8.8, 1.8 Hz, 1 H), 7.66–7.68 (m, 2 H), 7.50 (d, J = 5.7 Hz, 1 H), 7.03–7.05 (m, 2 H), 3.88 (s, 3 H), 3.57 (tt, J = 11.7, 3.2 Hz, 1 H), 1.93–2.01 (m, 4 H), 1.80–1.88 (m, 3 H), 1.50–1.57 (m, 2 H), 1.38–1.44 (m, 1 H). 13C NMR (126 MHz, CDCl3): δ = 165.7, 160.0, 142.5, 141.9, 137.0, 132.8, 128.7, 126.4, 125.5, 125.2, 124.5, 119.2, 114.6, 55.6, 41.8, 32.8, 27.1, 26.4.











